PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

LifeVest, Advanced Resuscitation Technology, IVTM Solutions at ACC 2011 - Zoll Lifevest Wearable Defibrillator, Advanced Resuscitation Technology, And Temperature Management Solutions To Be Showcased At ACC 2011 (NASDAQ GS: ZOLL) -
LifeVest, Advanced Resuscitation Technology, IVTM Solutions at ACC 2011


NewswireToday - /newswire/ - Chelmsford, MA, United States, 2011/03/31 - Zoll Lifevest Wearable Defibrillator, Advanced Resuscitation Technology, And Temperature Management Solutions To Be Showcased At ACC 2011 (NASDAQ GS: ZOLL) - NASDAQ: ZOLL

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it will display the LifeVest®Wearable Defibrillator, the AutoPulse®Non-invasive Cardiac Support Pump, R Series® Code-Ready® Defibrillators and its Intravascular Temperature Management (IVTM™) technology, in Booth 4027 at the 2011 American College of Cardiology Annual Scientific Session & Expo meeting April 2-5 at the Ernest N. Morial Convention Center in New Orleans.

An Industry-Expert Theater event focused on the LifeVest entitled “Post-MI SCA Risk and Screening: The Role of the Wearable Defibrillator,” will be presented by Ralph J. Verdino, M.D., University of Pennsylvania, Sunday, April 3, 3:45 pm. in Hall C #2300.

The following four abstracts will also feature the LifeVest in the poster session area, Hall F:

• Nicole Bianco, Ph.D., ZOLL, will present “Long-Term Mortality Risk in Post-Myocardial Infarct Patients Resuscitated by a Wearable Cardiac Defibrillator,” Sunday, April 3, 10 am.
• Thomas F. Deering, M.D., Piedmont Heart Institute, will present “Wearable Defibrillator Use after Myocardial Infarction: Results of the WAMI Registry,” Monday, April 4, 3:30 pm.
• Mohan Rao, M.D., University of Rochester School of Medicine and Dentistry, will present “Wearable Defibrillator in Congenital Heart Disease and Inherited Arrhythmia: A Multicenter Experience,” Monday, April 4, 3:30 pm.
• Robert Hanson, D.O., Pontiac Osteopathic Hospital, will present “Clinical Outcomes among Patients Using a Wearable Defibrillator,” Tuesday, April 5, 9:30 am.

LifeVest Provides Protection for Patients at Risk of SCA
The LifeVest is worn by patients at risk for sudden cardiac arrest (SCA), providing protection during their changing condition and while permanent SCA risk has not been established. The LifeVest allows a patient’s physician time to assess his or her long-term arrhythmic risk and make appropriate plans. The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. The LifeVest continuously monitors a patient’s heart and, if a life-threatening heart rhythm is detected, the device delivers a treatment shock to restore normal heart rhythm.

The LifeVest is used for a wide range of patient conditions or situations, including following a heart attack, before or after bypass surgery or stent placement, as well as for those with cardiomyopathy or congestive heart failure that places them at particular risk.
Additional products on display from ZOLL include:

• The AutoPulse, classified as a Class IIb device in the new 2010 AHA Guidelines, is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest, improving blood flow to the heart and brain during SCA. The AutoPulse delivers high-quality, uninterrupted CPR chest compressions to maintain myocardial and cerebral perfusion even when moving patients, traveling in an ambulance or while undergoing PCI. Additionally, it offers the benefit of freeing up clinicians to focus on other life-saving interventions.
• The R Series Code-Ready Defibrillators are designed to extend “Simple, Smart and Ready” defibrillation to every hospital department through advanced, cost-effective solutions for resuscitation. The original R Series ALS, and the newer R Series Plus, which has both AED and ALS capabilities at the touch of a button, offer See-Thru CPR®, a breakthrough technology that filters out CPR artifact from the ECG to reduce CPR interruptions. Like all ZOLL defibrillators, the R Series also features Real CPR Help® audio and visual feedback for the correct depth and rate of chest compressions.
• Intravascular Temperature Management (IVTM) offers health care providers the power and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients. The Thermogard XP® delivers accurate, easy-to-use and cost-effective control for both cooling and warming applications.

About ZOLL Medical Corporation
ZOLL Medical Corporation ( develops and markets medical devices and related software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company for the past three years, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.

Copyright © 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AutoPulse, LifeVest, Real CPR Help, R Series, See-Thru CPR, Thermoguard XP, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. All product names are the property of their respective owners.

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: ZOLL Medical Corporation


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

LifeVest, Advanced Resuscitation Technology, IVTM Solutions at ACC 2011

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Diane Egan - 
978-421-9637 degan[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From ZOLL Medical Corporation / Company Profile

Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing
GE Healthcare’s Biosafe Announces Sefia Platform to Address Multiple Steps in Cell Therapy Production Process
Leader Biomedical Group Enters APAC Market with New Offices in Malaysia
ZOLL to Showcase Advanced Resuscitation, Pediatric CPR, and Temperature Management Devices at 2016 ENA Annual Conference
Sparta Systems Partners with Navitas to Provide Comprehensive Solution for IDMP Compliance
Agfa HealthCare to Demonstrate its Integrated Care, Enterprise Imaging and Digital Radiography Solutions At SIRM 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  Intrinsic Executive Search Ltd

  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (